CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Fibrogen Inc   (NASDAQ: FGEN)
Other Ticker:  
 

Fibrogen Inc 's Long Term Debt to Equity

FGEN's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth

 


In Q1 2025 Fibrogen Inc had stockholder deficit.

Within Major Pharmaceutical Preparations industry Fibrogen Inc achieved the lowest Long Term Debt to Equity in the first quarter 2025. While total ranking remained the same in the first quarter 2025 compared to the previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debts FGEN´s has?
What are FGEN´s Equity?


FGEN Long Term Debt to Equity (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3		 (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1
Y / Y Equity Change - - - - -
Y / Y Long Term Debt Change 1.67 % 1.61 % 1.55 % 1.5 % -
Long Term Debt to Equity MRQ - - - - -
FGEN's Total Ranking # # # # #
Seq. Equity Change - - - - -
Seq. Long Term Debt Change 0.45 % 0.43 % 0.42 % 0.37 % 0.39 %

New: More FGEN's historic Long Term Debt to Equity Ratios >>


Long Term Debt to Equity first quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Fibrogen Inc 's Equity $ -196 Millions Visit FGEN's Balance sheet
Fibrogen Inc 's Long Term Debt $ 73 Millions Visit FGEN's Balance sheet
Source of FGEN's Sales Visit FGEN's Sales by Geography


Cumulative Fibrogen Inc 's Long Term Debt to Equity

FGEN's Long Term Debt to Equity for the trailling 12 Months

FGEN Long Term Debt to Equity

 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months
Y / Y Equity TTM Growth - - - - -
Y / Y Long Term Debt TTM Growth 1.58 % 35.14 % 102.28 % 303.72 % -
Long Term Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth - - - - -
Seq. Long Term Debt TTM Growth 0.42 % 0.4 % 0.39 % 0.37 % 33.59 %

FGEN Company Profile >> Back to FGEN Financial Strength Comparisons >> Compare FGEN Debt to Equity Ratio to its Competitors

On the trailing twelve months basis During the 12 months period ending Q1 2025 company had stockholder deficit.
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry FGEN recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debts FGEN´s has?
What are FGEN´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Mar 31 2025, within Major Pharmaceutical Preparations Industry Long Term Debt to EquityMar 31 2025 MRQ Long Term DebtMar 31 2025 MRQ Equity

Date modified: 2025-05-15T04:07:47+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com